Related Experiment Videos
Current and future management of childhood diarrhoea
1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Room No. 3054, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. bhanmk@medinst.ernet.in
Insights
Diarrhoea significantly impacts child growth, despite oral rehydration therapy (ORT) reducing hospitalizations. Further research seeks better treatments to reduce diarrhoea duration and severity, emphasizing malnutrition control.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Diarrhoea remains a critical global health issue, particularly affecting infants and children, leading to growth retardation.
- While oral rehydration therapy (ORT) has decreased mortality and hospitalization, approximately 1 million deaths annually in South-East Asia are still linked to diarrhoea.
- Current World Health Organization guidelines recommend ORT with continued feeding and antibiotics for specific infections, yet demand for additional drug therapies persists.
Purpose of the Study:
- To explore advancements in managing childhood diarrhoea.
- To identify strategies for reducing diarrhoeal duration and severity beyond current ORT protocols.
- To highlight the importance of integrated approaches, including nutritional support, in diarrhoeal disease management.
Main Methods:
- Review of current diarrhoea management strategies and their effectiveness.
- Analysis of ongoing research into improved oral rehydration solutions.
- Investigation of potential adjunct therapies for reducing stool output and disease severity.
Main Results:
- Oral rehydration therapy (ORT) has shown success in reducing hospitalizations and mortality.
- Despite ORT's acceptance, there is continued interest in pharmacological interventions to shorten diarrhoea.
- Malnutrition is identified as a crucial factor influencing the duration and severity of acute diarrhoea.
Conclusions:
- Continued research is essential for developing enhanced ORT or effective adjunct therapies.
- Therapeutic strategies must prioritize safety and targeted action to reduce stool output.
- Effective control of malnutrition is paramount for mitigating the impact of acute diarrhoea in children.
Abstract:
Diarrhoea continues to have a devastating impact in infants and children. It is a major cause of retarded growth. Substantial declines in hospitalization rates and possibly in the mortality due to diarrhoea have occurred following the launch of programmes based on oral rehydration therapy, and yet about 1 million diarrhoea-related deaths occur each year in South-East Asia. The World Health Organization currently recommends oral rehydration therapy plus continued breast- and complementary feeding for children with diarrhoea, and antibiotics for dysentery or associated systemic infection. Although oral rehydration therapy has achieved substantial acceptance, physicians and families continue to prescribe and seek drug therapy to reduce diarrhoeal duration and severity. Research is aimed at developing improved oral rehydration salt solutions or identifying adjunct therapy that will provide substantial benefit in reducing stool output together with safety and selectivity of action. It must, however, be recognized that control of malnutrition is a key requirement to reduce the duration and severity of acute diarrhoea.